viroporin
viral
protein
ion
channel
ic
activ
play
import
role
sever
process
includ
viru
replic
pathogenesi
mani
coronavirus
cov
encod
two
viroporin
sever
acut
respiratori
syndrom
cov
sarscov
encod
three
protein
e
addit
protein
e
pdzbind
motif
pbm
potenti
bind
cellular
protein
contain
pdz
domain
make
potenti
import
control
cell
function
present
work
compar
studi
function
motif
includ
within
sarscov
viroporin
perform
mostli
focus
role
ic
pbm
e
protein
result
show
fulllength
e
protein
requir
maxim
sarscov
replic
virul
wherea
viroporin
minor
impact
activ
viru
miss
e
protein
viabl
wherea
presenc
either
protein
function
pbm
restor
viru
viabil
e
protein
ic
activ
presenc
pbm
necessari
virul
mice
contrast
presenc
absenc
homolog
motif
protein
influenc
viru
pathogen
therefor
domin
ic
pbm
protein
e
protein
demonstr
induct
pathogenesi
mice
aguilella
vm
sola
enjuan
l
role
sever
acut
respiratori
syndrom
coronaviru
viroporin
e
replic
pathogenesi
mbio
http
doi
import
collect
result
demonstr
key
role
ion
channel
pbm
domain
optim
viru
replic
pathogenesi
suggest
viral
viroporin
pbm
suitabl
target
antivir
therapi
mutat
attenu
sarscov
vaccin
keyword
coronaviru
pbm
pdz
sarscov
viroporin
c
oronavirus
cov
pathogen
respons
wide
rang
exist
emerg
diseas
human
domest
companion
anim
cov
caus
sever
acut
respiratori
syndrom
sarscov
identifi
southeast
china
rapidli
spread
worldwid
countri
within
month
infect
peopl
mortal
approxim
case
sarscov
sinc
reappear
human
cov
includ
one
similar
sarscov
wide
dissemin
among
bat
circul
world
make
futur
outbreak
possibl
fact
novel
cov
middl
east
respiratori
syndrom
coronaviru
merscov
identifi
septemb
two
human
patient
sever
respiratori
diseas
saudi
arabia
sinc
report
laboratoryconfirm
case
least
death
virul
contrast
e
protein
requir
virul
protein
ic
activ
character
planar
lipid
bilay
show
form
nonvoltageg
ion
channel
furthermor
identifi
residu
locat
protein
involv
ic
activ
potenti
interdepend
three
viroporin
describ
sarscov
studi
delet
singl
viroporin
differ
combin
two
viroporin
variant
miss
e
protein
viabl
indic
presenc
least
one
protein
essenti
viru
viabil
furthermor
shown
either
protein
maintain
pbm
compens
absenc
fulllength
protein
result
suggest
pbm
interact
cellular
protein
pdz
domain
chang
cell
metabol
enhanc
viru
replic
pathogen
identif
inhibit
specif
cellular
pathway
affect
interact
may
crucial
identif
new
antivir
strategi
studi
role
sarscov
viroporin
viru
replic
virul
three
mutant
virus
lack
one
gene
recombin
sar
rsar
engin
mouseadapt
infecti
cdna
clone
analysi
growth
kinet
mutant
vero
cell
supernat
fig
use
determin
requir
replic
cellassoci
viru
also
analyz
h
postinfect
hpi
show
result
similar
observ
releas
viru
see
fig
supplement
materi
mutant
grew
lower
titer
parent
wildtyp
wt
viru
fig
howev
mutant
show
titer
around
pfuml
titer
decreas
slightli
pfuml
result
show
protein
requir
optim
viru
replic
cell
cultur
contrast
viru
reach
peak
titer
pfuml
similar
observ
parent
viru
evalu
requir
protein
e
optim
viru
growth
vivo
balbc
mice
infect
either
viroporin
delet
mutant
viral
titer
lung
determin
day
postinfect
dpi
fig
highest
titer
reach
dpi
titer
decreas
case
dpi
parent
virus
achiev
highest
titer
lung
tissu
around
pfug
dpi
pfug
dpi
howev
compar
parent
viru
titer
reduc
log
unit
case
viru
respect
interestingli
decreas
viru
titer
infect
greater
vivo
vitro
thu
protein
e
shown
critic
vitro
vivo
viru
replic
sarscov
viroporin
e
associ
virul
mous
model
evalu
relev
sarscov
e
viroporin
virul
balbc
mice
either
subject
mock
infect
infect
parent
one
delet
mutant
clinic
diseas
surviv
monitor
dpi
fig
mice
infect
virus
lack
either
e
protein
protein
recov
infect
surviv
although
mice
infect
viru
show
mild
diseas
symptom
contrast
mice
infect
parent
viru
viru
develop
manifest
seriou
diseas
lethargi
ruffl
fur
start
dpi
mice
die
dpi
clearli
show
e
protein
involv
sarscov
virul
mous
model
seem
play
major
role
character
ic
activ
protein
planar
lipid
bilay
ic
activ
protein
e
requir
sarscov
replic
virul
howev
relev
ic
activ
protein
known
studi
protein
planar
lipid
bilay
identifi
amino
acid
involv
ion
conduct
system
use
high
sensit
allow
detect
electr
current
singl
ion
channel
end
baculoviru
engin
express
parent
protein
cell
conduct
purifi
protein
evalu
presenc
kcl
planar
lipid
bilay
biolog
relev
mix
dopc
dop
dope
ratio
wtwt
composit
similar
intracellular
organel
membran
endoplasm
reticulum
er
golgi
intermedi
compart
ergic
singlechannel
conduct
estim
statist
analysi
current
jump
amplitud
procedur
allow
reliabl
estim
probabl
valu
current
chang
everi
time
new
channel
insert
disappear
although
sever
channel
insert
magnitud
current
singl
channel
could
discrimin
current
jump
correspond
ind
cell
infect
wildtyp
wt
black
fill
circl
blue
fill
squar
red
fill
circl
green
fill
diamond
sarscov
moi
cultur
supernat
collect
hpi
titrat
plaqu
assay
result
repres
three
replic
experi
b
group
six
balbc
mice
infect
pfu
either
parent
viru
wt
black
column
genet
engin
virus
lack
e
protein
blue
column
protein
red
column
protein
green
column
dpi
mice
group
sacrif
determin
lung
viru
titer
data
summar
two
replic
experi
data
repres
mean
standard
deviat
sd
p
valu
p
valu
p
valu
pendent
event
measur
condit
appli
voltag
mv
histogram
current
jump
amplitud
record
trace
show
frequent
event
correspond
singlechannel
conduct
pa
fig
b
simultan
burst
two
three
ion
channel
also
observ
although
much
lower
frequenc
fig
test
behav
voltageg
ic
activ
also
measur
planar
lipid
bilay
condit
differ
voltag
presenc
monoval
nacl
dival
cacl
cation
fig
case
linear
currentvoltag
iv
relationship
obtain
demonstr
channel
display
resist
ohmic
behavior
posit
neg
potenti
result
indic
protein
ic
neither
open
close
specif
electr
potenti
measur
revers
potenti
e
rev
ion
channel
defin
voltag
need
appli
yield
zero
electr
current
ion
concentr
gradient
across
membran
method
choic
quantifi
ion
select
determin
sign
e
rev
provid
quick
estim
channel
select
prefer
cation
anion
compar
measur
e
rev
theoret
e
rev
would
obtain
case
neutral
pore
ie
repres
differ
cation
anion
intrins
mobil
select
ion
channel
infer
theoret
e
rev
calcul
use
goldmanhodgkinkatz
ghk
equat
replac
permeabl
ratio
p
p
solut
diffus
coeffici
ratio
higher
lower
similar
measur
e
rev
valu
indic
anion
select
cation
select
select
respect
interestingli
presenc
monoval
ion
na
k
protein
ic
show
weak
cation
select
howev
presenc
ca
channel
behav
neutral
channel
prefer
anion
cation
tabl
taken
togeth
result
indic
least
na
k
ca
conduct
protein
ic
identif
amino
acid
involv
protein
ic
activ
order
identifi
amino
acid
necessari
protein
ic
activ
set
recombin
baculovirus
rbv
express
mutat
protein
engin
amino
acid
substitut
creat
disrupt
ic
activ
minim
impact
threedimension
structur
mutat
residu
predict
face
lumen
pore
protein
structur
yet
experiment
determin
silico
model
use
select
residu
potenti
face
lumen
pore
protein
three
tmd
mutant
chang
singl
tmd
two
tmd
tmd
engin
tabl
mutant
protein
express
insect
cell
purifi
ic
activ
evalu
planar
lipid
bilay
fig
mutant
retain
ic
activ
tmd
variant
consist
import
predict
silico
model
resolv
exact
residu
necessari
protein
ic
activ
complementari
set
baculovirus
incorpor
singl
amino
acid
substitut
within
mutant
gener
mutant
protein
express
purifi
ic
activ
evalu
point
mutant
point
mutant
complet
abrog
protein
ic
activ
wherea
point
mutant
show
conduct
equival
moder
decreas
seen
wt
protein
respect
therefor
result
identifi
amino
acid
could
mutat
elimin
protein
ic
activ
protein
ic
activ
requir
sarscov
replic
virul
studi
relev
protein
ic
activ
viru
replic
virul
follow
collect
fulllength
rsarscov
without
protein
ic
activ
gener
introduc
specif
mutat
gene
tmd
virus
similar
respect
growth
kinet
vero
cell
fig
indic
replic
significantli
affect
alter
protein
ic
activ
requir
protein
ic
activ
vivo
also
studi
measur
titer
ic
mutant
lung
infect
balbc
mice
dpi
fig
peak
titer
reach
dpi
decreas
around
log
unit
dpi
case
everi
mutant
show
replic
level
similar
seen
wt
strain
around
pfug
lung
tissu
dpi
pfug
dpi
except
titer
least
log
unit
lower
seen
rest
virus
pfug
dpi
pfug
dpi
fig
result
indic
protein
ic
activ
essenti
sarscov
replic
mous
lung
requir
protein
ic
activ
sarscov
virul
studi
two
independ
experi
first
balbc
mice
infect
virul
viru
control
attenu
viru
control
one
rsarscov
mutant
tmd
fig
clinic
diseas
surviv
evalu
day
mice
infect
parent
viru
mutant
show
diseas
symptom
start
dpi
die
dpi
respect
mice
infect
mutant
show
acut
diseas
start
dpi
mice
die
dpi
contrast
mice
infect
either
tmd
mutant
recov
diseas
surviv
similarli
mice
infect
attenu
variant
fig
experi
virus
recov
lung
moribund
mice
gene
sequenc
compensatori
mutat
restor
ic
activ
identifi
case
result
suggest
tmd
mutant
attenu
icindepend
manner
sinc
mutant
margin
attenu
second
virul
experi
mice
infect
rsarscov
incorpor
protein
point
mutat
parent
variant
serv
virul
attenu
control
respect
point
mutant
caus
sever
diseas
mortal
dpi
similarli
mice
infect
wt
parent
contrast
infect
variant
surviv
fig
compensatori
mutat
restor
ic
activ
identifi
experi
confirm
protein
ic
activ
essenti
sarscov
virul
mous
model
use
pbm
protein
requir
sarscov
replic
virul
analyz
requir
pbm
protein
replic
virul
viru
lack
function
pbm
protein
engin
partial
overlap
protein
pbm
core
sequenc
svpl
disrupt
amino
acid
substitut
gmsm
codon
care
select
ensur
protein
mutat
growth
mutant
vero
cell
lung
infect
mice
seen
fig
also
mutant
pathogen
parent
viru
fig
result
indic
mous
model
replic
viru
virul
independ
pbm
protein
simultan
requir
viroporin
sarscov
order
studi
interdepend
sarscov
viroporin
possibl
combin
singl
doubl
tripledelet
mutant
engin
tabl
combin
effici
rescu
remark
except
tripl
mutant
one
lack
e
protein
e
viru
doubledelet
mutant
show
significantli
reduc
titer
pfuml
respect
compar
mutant
parent
viru
although
role
protein
weekold
balbc
mice
subject
mock
infect
pb
gray
fill
squar
infect
pfu
parent
wildtyp
viru
wt
black
fill
hexagon
genet
engin
mutant
lack
protein
green
fill
circl
lack
protein
pbm
red
fill
diamond
mean
level
weight
loss
left
graph
surviv
right
graph
dpi
repres
group
data
summar
two
replic
experi
equival
result
error
bar
repres
standard
deviat
mous
weight
data
describ
viru
replic
titer
virus
miss
e
significantli
lower
titer
virus
also
everi
one
viabl
mutant
virus
lack
either
e
protein
show
plaqu
size
significantli
smaller
seen
wt
virus
result
show
least
either
protein
e
protein
must
present
viru
viabil
indic
one
protein
could
provid
activ
requir
viru
growth
sarscov
protein
subcellular
local
begin
understand
natur
replac
e
protein
vice
versa
replic
sarscov
assess
cellular
local
protein
sarscov
e
protein
local
ergic
less
known
protein
local
potenti
coloc
e
protein
first
studi
infect
vero
cell
wt
rsarscov
confoc
microscopi
analysi
hpi
show
protein
locat
differ
cell
subcompart
infect
pearson
coeffici
valu
see
tabl
supplement
materi
protein
mainli
accumul
unidentifi
perinuclear
compart
differ
ergic
fig
e
protein
ic
activ
promot
virul
releas
calcium
ergic
lead
inflammasom
activ
show
protein
ic
activ
involv
viru
virul
extend
result
next
determin
whether
local
known
cellular
calcium
reservoir
ie
er
golgi
apparatu
mitochondria
use
specif
marker
includ
protein
disulfid
isomeras
pdi
er
marker
k
golgi
marker
aconitas
mitochondrion
marker
fig
also
subcellular
compart
analyz
coloc
protein
use
antibodi
ab
na
k
atpas
plasma
membran
marker
earli
endosom
marker
late
endosom
marker
lysosom
marker
fig
pearson
coeffici
case
tabl
overal
protein
local
main
intracellular
calcium
storag
locat
suggest
locat
site
facilit
increas
cytosol
calcium
level
collect
result
suggest
ic
activ
protein
e
share
two
protein
function
respons
replac
fulllength
e
protein
identif
candid
motif
respons
replac
e
protein
identifi
e
protein
domain
essenti
absenc
fulllength
protein
set
mutant
engin
substitut
delet
throughout
e
protein
sequenc
fig
data
detect
threshold
infecti
bacteri
artifici
chromosom
bac
clone
mutant
two
independ
gener
bac
analyz
fig
collect
data
strongli
support
idea
requir
pbm
viabil
sarscov
fig
indic
e
protein
function
pbm
compens
loss
fulllength
protein
addit
mutant
gener
protein
pbm
mutat
context
fulllength
e
protein
delet
rescu
viru
possibl
fig
show
necess
least
one
two
protein
function
pbm
viru
viabil
context
complet
delet
either
e
gene
gene
also
viru
titer
significantli
decreas
one
passag
mutant
rev
compar
viru
fig
addit
virus
small
delet
throughout
c
terminu
e
protein
viabl
possibl
due
requir
protein
nativ
structur
length
essenti
pbm
avail
bind
viral
cellular
protein
fig
analyz
relev
protein
shorten
fold
addit
mutant
construct
background
fill
delet
alaninerich
sequenc
order
restor
origin
length
fold
e
protein
fig
mutant
viru
viabl
indic
lack
sequenc
specif
observ
function
altern
role
domain
locat
middl
e
protein
c
terminu
complet
rule
analysi
subcellular
local
sarscov
immunofluoresc
vero
cell
grown
coverslip
infect
rsarscov
moi
fix
paraformaldehyd
hpi
cell
label
antibodi
specif
protein
shown
green
na
k
atpas
plasma
membran
marker
earli
endosom
marker
late
endosom
marker
lysosom
marker
shown
red
case
nuclei
stain
dapi
blue
studi
replic
depend
pbm
e
collect
mutant
one
epbm
e
pbm
viral
pbm
sequenc
remov
gener
fig
three
pbm
mutant
viabl
show
consequ
presenc
e
protein
pbm
protein
complet
delet
differ
seen
pbm
miss
howev
viru
titer
decreas
viral
pbm
miss
comparison
level
seen
parent
viru
mutant
lack
one
pbm
fig
remark
pbm
present
e
protein
viru
highli
virul
independ
whether
protein
includ
pbm
fig
contrast
mortal
significantli
decreas
e
protein
lack
pbm
regardless
presenc
absenc
pbm
within
protein
result
indic
impact
presenc
absenc
e
protein
pbm
virul
definit
determin
whether
viru
pathogen
nonpathogen
respect
contrast
presenc
absenc
protein
without
pbm
littl
impact
viru
virul
illustr
much
greater
relev
e
protein
pbm
pbm
respect
viru
pathogen
viroporin
highli
relev
viral
replic
pathogenesi
requir
larg
number
physiolog
process
make
studi
field
grow
interest
cov
usual
encod
two
viroporin
includ
conserv
structur
e
protein
addit
one
encod
accessori
gene
role
viroporin
replic
virul
studi
detail
sarscov
e
protein
though
role
replic
also
establish
pedv
merscov
encod
two
protein
e
homologu
sarscov
e
protein
respect
ic
activ
merscov
e
protein
previous
describ
potenti
ic
activ
protein
yet
studi
detail
howev
due
similar
sarscov
pedv
ic
conduct
protein
expect
furthermor
merscov
e
protein
put
pbm
carboxi
terminu
similarli
sarscov
e
protein
sarscov
encod
three
viroporin
e
previous
shown
sarscov
mutant
lack
e
protein
attenu
mice
show
remov
protein
slightli
reduc
viru
titer
vitro
compar
result
seen
parent
viru
fig
contrast
titer
mutant
reduc
vivo
fig
indic
protein
requir
optim
sarscov
replic
result
agreement
previou
studi
show
slight
reduct
titer
vero
cell
nevertheless
note
mice
previou
studi
infect
human
sarscov
urbani
strain
caus
mild
murin
infect
contrast
mouseadapt
strain
reduct
titer
infect
mutant
virus
may
reflect
role
membran
rearrang
increas
level
intracellular
vesicl
promot
nonlyt
releas
viral
particl
altern
protein
may
induc
apoptosi
may
enhanc
inflamm
activ
nuclear
factor
kappa
b
nfkb
lead
product
proinflammatori
cytokin
rant
fact
histopatholog
analysi
lung
mice
show
minim
damag
cellular
infiltr
dpi
wherea
mice
infect
sarscov
parent
viru
reveal
interstiti
peribronchi
cell
infiltr
edema
alveolar
bronchiolar
airway
dpi
mainli
dpi
see
fig
supplement
materi
suggest
attenu
mutant
may
due
inabl
activ
exacerb
proinflammatori
respons
result
surviv
infect
mice
fact
similar
result
obtain
lung
mice
infect
also
led
attenu
downregul
host
proinflammatori
respons
show
delet
sarscov
protein
alon
measur
effect
replic
virul
mice
fig
line
fact
lost
sarscov
pandem
virus
lack
gene
recov
patient
die
sarscov
infect
support
idea
also
requir
virul
human
howev
virus
lack
protein
protein
also
delet
titer
lower
seen
parent
viru
indic
simultan
delet
two
protein
may
contribut
replic
least
small
extent
residu
involv
e
protein
ic
activ
previous
identifi
activ
essenti
replic
virul
previous
report
e
ion
channel
activ
inflammasom
calcium
releas
intracellular
store
ic
activ
sarscov
e
protein
exert
membran
ergic
facilit
releas
ca
intracellular
compart
contribut
activ
inflammasom
complex
lead
releas
proinflammatori
cytokin
tumor
necrosi
factor
alpha
accumul
cytokin
promot
exacerb
proinflammatori
respons
lead
death
thu
e
protein
ic
activ
virul
factor
similar
ic
activ
influenza
viru
rotaviru
e
protein
ic
activ
promot
virul
via
inflammasom
activ
hypothes
protein
ic
activ
could
act
similar
way
howev
correl
found
protein
ic
activ
sarscov
titer
pathogen
conclud
mous
model
ic
activ
protein
affect
replic
virul
way
e
protein
howev
sarscov
protein
tmd
mutant
display
ic
activ
attenu
principl
possibl
explan
observ
threeaminoacid
mutat
present
mutant
mutant
tmd
could
disrupt
function
protein
ic
activ
nevertheless
virus
includ
point
mutat
disrupt
ic
activ
less
like
affect
function
protein
mutat
tmd
respect
complet
virul
mutant
show
titer
lung
infect
mice
impact
mutant
viru
replic
virul
may
principl
due
exclus
effect
protein
function
differ
ic
activ
tmd
mutant
maintain
titer
nativ
viru
could
explain
mutat
structur
compens
one
two
simultan
present
protein
overal
result
indic
protein
ic
activ
involv
viru
virul
sever
factor
may
account
differ
degre
relev
sarscov
e
protein
ic
activ
two
protein
local
differ
subcellular
compart
fig
suggest
ic
activ
two
protein
regul
ion
transport
differ
compart
e
protein
locat
ergic
induc
calcium
efflux
sarscov
infect
activ
inflammasom
complex
lead
acut
proinflammatori
respons
associ
viru
pathogen
protein
found
main
intracellular
ca
storag
locat
fig
ic
activ
like
induc
cellular
pathway
less
relev
pathogenesi
note
sarscov
protein
subcellular
local
previous
studi
transfect
cell
plasmid
overexpress
tag
variant
protein
lead
conclus
protein
locat
golgi
compart
cell
surfac
studi
also
perform
context
infect
without
use
subcellular
compart
marker
lead
observ
protein
locat
cell
membran
cytoplasm
nucleu
analysi
context
infect
use
marker
cellular
compart
could
conclud
sarscov
protein
locat
previous
describ
compart
furthermor
knowledg
cellular
locat
protein
accumul
remain
elus
analysi
perform
use
marker
follow
differ
intracellular
compart
er
golgi
apparatu
mitochondria
earli
late
endosom
lysosom
plasma
membran
e
protein
pbm
anoth
virul
factor
sarscov
homolog
motif
present
protein
howev
analysi
mutant
lack
pbm
show
effect
viru
product
virul
fig
requir
protein
e
pbm
domin
sarscov
virul
comparison
requir
protein
pbm
fig
furthermor
sarscov
e
protein
includ
pbm
virul
presenc
absenc
protein
pbm
wherea
revers
situat
presenc
protein
pbm
e
protein
lack
pbm
viru
alway
attenu
reinforc
idea
domin
e
protein
pbm
viru
pathogen
protein
interact
e
protein
pbm
syntenin
pdz
motif
activ
mitogenactiv
protein
kinas
mapk
pathway
promot
acut
proinflammatori
respons
lead
death
howev
viral
pbm
like
show
prefer
distinct
pdz
domain
motif
present
cellular
protein
isoform
contain
pdz
domain
sarscov
e
protein
pbm
sequenc
differ
dllv
svpl
respect
like
interact
differ
network
pdzcontain
cellular
protein
protein
pbm
interact
cellular
pdz
protein
like
induc
signal
pathway
either
pathogen
host
activ
lower
intens
due
reduc
affin
viral
pbm
cellular
pdz
domain
explain
virus
without
pbm
show
signific
differ
pathogen
howev
given
protein
pbm
requir
viru
viabil
fulllength
e
protein
miss
confirm
pathway
activ
protein
pbm
impact
viru
replic
order
studi
interdepend
sarscov
viroporin
effect
delet
one
viroporin
simultan
delet
two
three
viroporin
determin
protein
includ
determin
potenti
relev
absenc
viroporin
show
signific
impact
viral
growth
condit
protein
e
protein
absent
contrast
observ
sarscov
viabl
e
protein
absent
viabil
rescu
presenc
either
e
show
e
protein
could
compens
loss
viroporin
provid
carri
function
pbm
fig
conclus
reinforc
result
obtain
five
differ
recombin
virus
even
biolog
relev
rapid
revers
stop
codon
introduc
aa
upstream
carboxi
terminu
e
protein
mutant
revers
identifi
mutant
presum
revers
singl
alter
codon
occur
easili
chang
epbm
delet
perform
fig
result
also
show
protein
carri
pbm
could
compens
loss
e
protein
could
restor
viru
replic
virul
fig
idea
requir
sarscov
pbm
viru
replic
virul
also
support
previou
observ
reveal
mutant
evolv
introduc
new
transmembran
protein
pbm
compens
loss
whole
e
protein
passag
either
cell
cultur
vivo
addit
passag
mice
spontan
gain
intern
pbm
protein
pbm
also
phylogenet
conserv
protein
sarscov
merscov
isol
human
civet
cat
dromedari
camel
bat
fig
reinforc
idea
relev
pbm
coronaviru
viabil
viral
pbmcellular
pdz
interact
previous
describ
sever
virus
instanc
pbm
oncoprotein
human
papillomaviru
interact
sever
cellular
protein
contain
pdz
motif
lead
tumorigenesi
viru
dissemin
hand
differ
strain
rabi
viru
rabv
includ
varieti
pbm
g
protein
differenti
contribut
viral
virul
activ
varieti
signal
pathway
case
influenza
viru
protein
pbm
locat
carboxi
terminu
possibl
involv
enhanc
virul
addit
vaccinia
viru
protein
pdz
domain
pbm
influenc
viral
spread
overal
conclud
sarscov
e
protein
common
two
import
characterist
ic
activ
pbm
ic
pbm
e
protein
involv
sarscov
virul
replic
wherea
correspond
motif
protein
show
domin
e
protein
pbm
ic
activ
protein
homologu
howev
protein
pbm
becam
relev
viru
viabil
absenc
fulllength
e
protein
result
contribut
better
understand
role
cov
ic
activ
pbm
impact
ration
design
futur
vaccin
antivir
virus
mouseadapt
parent
wildtyp
wt
recombin
virus
rescu
infecti
cdna
clone
gener
bacteri
artifici
chromosom
bac
gener
recombin
virus
virus
mutat
sarscov
viroporin
e
construct
infecti
cdna
clone
within
bacteri
artifici
chromosom
bac
plasmid
gener
e
delet
mutant
describ
previous
gene
delet
overlap
extens
pcr
use
primer
shown
tabl
supplement
materi
mutat
includ
delet
region
nt
sarscov
genom
result
delet
protein
retain
protein
disrupt
atg
start
codon
gene
point
mutat
nt
codon
pcr
product
gener
nt
sarscov
genom
digest
flank
swai
bamhi
site
clone
intermedi
plasmid
pbacsarspmeibamhisarscov
contain
sequenc
sarscov
infecti
cdna
clone
gener
plasmid
final
plasmid
digest
pmei
bamhi
fragment
carri
delet
reinsert
similarli
digest
plasmid
gener
construct
delet
mutant
dna
fragment
contain
nt
sarscov
genom
flank
restrict
site
xcmi
nhei
assembl
overlap
extens
pcr
use
templat
primer
indic
tabl
process
result
delet
first
nt
gene
without
affect
gene
final
pcr
product
digest
xcmi
nhei
clone
intermedi
plasmid
pbacbamhirsriisarscov
contain
nt
sarscov
infecti
cdna
clone
thu
obtain
plasmid
digest
bamhi
rsrii
fragment
carri
delet
gene
reinsert
gener
gener
mutant
mutat
ic
dna
fragment
contain
nt
sarscov
genom
produc
overlap
extens
pcr
use
plasmid
templat
primer
indic
tabl
follow
mutat
introduc
tca
gca
agc
gcc
tat
gct
cat
gct
tat
gct
tat
gct
caa
gca
includ
includ
includ
tmd
includ
pcr
product
digest
flank
swai
bamhi
site
clone
pbacpmeibamhisarscov
intermedi
plasmid
digest
pmei
bamhi
reclon
gener
infecti
sarscov
cdna
clone
mutat
mutat
pbm
sequenc
overlap
extens
pcr
perform
use
templat
primer
indic
tabl
result
dna
fragment
contain
nt
sarscov
genom
core
pbm
svpl
nt
agcgtgcctttg
replac
altern
sequenc
gmsm
nt
ggcatgtctatg
gene
overlap
region
care
taken
introduc
silent
mutat
orf
result
pcr
fragment
digest
flank
bamhi
xcmi
site
clone
intermedi
plasmid
pbacbamhirsriisarscov
result
plasmid
digest
bamhi
rsrii
fragment
carri
mutat
pbm
reinsert
gener
plasmid
virus
combin
delet
gene
mutat
throughout
e
gene
gener
digest
previous
describ
plasmid
epbm
epbm
bamhi
rsrii
clone
fragment
mutat
similarli
digest
plasmid
order
gener
recombin
baculovirus
protein
construct
sarscov
gene
clone
pfastbac
vector
invitrogen
contain
tobacco
etch
viru
tev
cleavabl
site
histidin
residu
fuse
c
terminu
construct
recombin
baculovirus
produc
follow
instruct
manufactur
invitrogen
recoveri
recombin
sarscov
variant
cdna
clone
bhk
cell
grown
confluenc
flask
transfect
g
infecti
cdna
clone
l
lipofectamin
invitrogen
accord
manufactur
specif
h
posttransfect
hpt
cell
trypsin
ad
confluent
vero
cell
monolay
grown
flask
incub
h
cell
supernat
harvest
passag
fresh
cell
recov
virus
clone
three
round
plaqu
purif
follow
standard
procedur
cell
vero
cell
bhk
cell
kindli
provid
e
snijder
univers
leiden
netherland
h
laud
de
virologi
et
immunologi
moleculari
inra
franc
respect
case
cell
grown
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
mm
hepe
mm
lglutamin
sigma
nonessenti
amino
acid
sigma
fetal
bovin
serum
fb
biowhittak
inc
viru
titrat
perform
vero
cell
previous
describ
mice
eightweekold
specificpathogenfre
balbc
ola
hsd
femal
mice
purchas
harlan
laboratori
maintain
addit
week
anim
care
facil
nation
center
biotechnolog
madrid
infect
experi
mice
anesthet
isofluran
intranas
inocul
week
age
pfu
indic
virus
work
infect
anim
perform
biosafeti
level
laboratori
cisa
inia
technician
wear
person
protect
equip
gener
polyclon
antibodi
specif
sarscov
protein
synthet
peptid
correspond
residu
sarscov
protein
cesitaqpvkidna
gener
use
immun
two
rabbit
biogen
berlin
germani
accord
standard
protocol
supplier
serum
collect
dpi
evalu
enzymelink
immunosorb
assay
elisa
immunofluoresc
western
blot
analysi
use
vero
cell
infect
sarscovwt
neg
control
viru
genom
sequenc
region
sarscov
genom
correspond
e
gene
sequenc
revers
transcriptas
pcr
rtpcr
briefli
total
rna
infect
cell
homogen
mous
lung
collect
purifi
use
rneasi
kit
qiagen
accord
manufactur
specif
rt
reaction
ng
rna
random
oligonucleotid
primer
thermoscript
revers
transcriptas
invitrogen
use
rt
product
subsequ
subject
pcr
use
vent
polymeras
new
england
biolab
follow
primer
pair
ggcgac
atttcaggcattaacgc
ggcacgctagtagtcgtcgtcggc
amplifi
gene
ev
ctcttcaggagttgctaatccagcaatgg
er
tccaggagttgtttaagcttctcaacggta
amplifi
nucleotid
includ
e
gene
ggaggttcaacaaga
gctctactcgcc
gacagttgatagtaacattaggtgtgc
amplifi
region
includ
gene
sequenc
assembl
comparison
parent
consensu
sequenc
perform
seqman
softwar
lasergen
madison
wi
growth
kinet
subconflu
monolay
confluenc
vero
cell
flask
infect
multipl
infect
moi
indic
virus
cultur
supernat
collect
h
postinfect
hpi
viru
titer
determin
previous
describ
analysi
cellassoci
viru
vero
cell
infect
moi
indic
virus
hpi
cell
recov
phosphatebuff
salin
pb
buffer
disrupt
four
freezethaw
cycl
sampl
centrifug
remov
cell
debri
supernat
titrat
previous
describ
viru
infect
growth
mice
balbc
mice
anesthet
isofluran
intranas
inocul
pfu
viru
mix
l
dmem
weight
loss
mortal
evalu
daili
determin
sarscov
titer
lung
homogen
pb
contain
iuml
penicillin
mgml
streptomycin
gml
gentamicin
gml
amphotericin
b
fungizon
use
gentlemac
dissoci
miltenyi
biotec
inc
viru
titrat
perform
vero
cell
previous
describ
viral
titer
express
pfu
count
per
gram
tissu
histopatholog
mice
sacrif
dpi
lung
remov
fix
zinc
formalin
embed
paraffin
histopatholog
examin
perform
section
stain
hematoxylineosin
ion
channel
reconstitut
ionic
current
record
planar
bilay
form
apposit
two
monolay
prepar
mixtur
dopc
dop
dope
dopcdopsdop
ratio
wtwt
avanti
polar
lipid
alabast
al
mix
pentan
mgml
lipid
ad
orific
teflon
partit
separ
two
ident
chamber
orific
pretreat
solut
hexadecanepentan
aqueou
solut
kcl
nacl
cacl
buffer
mm
hepe
ph
measur
perform
room
temperatur
ion
channel
insert
achiev
ad
l
gml
solut
recombin
protein
buffer
contain
acetonitrileisopropanol
one
side
chamber
refer
ci
side
electr
potenti
appli
use
agagcl
electrod
agaros
bridg
assembl
within
standard
pipett
tip
potenti
defin
posit
higher
ci
side
wherea
tran
side
set
ground
axopatch
amplifi
molecular
devic
sunnyval
ca
use
voltageclamp
mode
measur
current
appli
potenti
chamber
head
stage
isol
extern
nois
sourc
doubl
metal
screen
amun
manufactur
corp
philadelphia
pa
singlechannel
conduct
data
obtain
current
measur
condit
appli
potenti
mv
evalu
use
gaussian
fit
tool
sigma
plot
systat
softwar
inc
revers
potenti
e
rev
determin
follow
first
lipid
membran
form
given
salt
concentr
gradient
second
one
sever
channel
insert
bilay
net
ionic
current
appear
due
concentr
gradient
third
ionic
current
channel
channel
manual
set
zero
adjust
appli
potenti
potenti
need
achiev
zero
current
correct
use
valu
correspond
liquid
junction
potenti
electrod
salt
bridg
obtain
final
e
rev
confoc
microscopi
vero
cell
grown
confluenc
glass
coverslip
infect
wt
sarscov
moi
pfucel
hpi
medium
remov
cell
wash
twice
pb
fix
paraformaldehydepb
min
room
temperatur
cell
subsequ
wash
twice
pb
permeabil
min
icecold
methanol
block
pb
contain
fb
min
room
temperatur
immunofluoresc
perform
use
mous
ab
specif
sarscov
e
protein
gener
describ
refer
protein
disulfid
isomeras
pdi
abcam
inc
k
abcam
inc
aconitas
abcam
inc
bd
bioscienc
bd
bioscienc
santa
cruz
biotechnolog
na
k
atpas
santa
cruz
biotechnolog
rabbit
ab
specif
sarscov
protein
primari
antibodi
dilut
pb
contain
fb
incub
min
room
temperatur
coverslip
wash
four
time
pb
incub
secondari
antibodi
perform
alexa
alexa
antibodi
specif
differ
speci
invitrogen
dilut
pb
contain
fb
incub
min
room
temperatur
nuclei
stain
use
dapi
sigma
coverslip
mount
prolong
gold
antifad
reagent
invitrogen
examin
leica
confoc
microscop
leica
microsystem
inc
imag
analysi
perform
use
imagej
jacop
plugin
three
area
per
imag
pixel
high
accumul
protein
analyz
determin
pearson
coeffici
pc
pc
valu
consid
neg
coloc
partial
coloc
consid
occur
pc
valu
pc
valu
consid
posit
coloc
product
purif
sarscov
protein
mutant
variant
recombin
baculoviru
cell
confluenc
infect
moi
construct
specifi
gener
recombin
virus
section
incub
h
cell
harvest
resuspend
lysi
buffer
mm
trishcl
mm
nacl
triton
ph
supplement
proteas
inhibitor
cocktail
sigma
protein
extract
centrifug
g
min
pellet
resuspend
lysi
buffer
urea
mm
trishcl
mm
nacl
igep
mm
mm
imidazol
ph
sampl
sonic
three
time
time
centrifug
g
min
final
protein
present
supernat
purifi
metal
affin
chromatographi
imac
use
cobalt
resin
clontech
follow
manufactur
instruct
everi
fraction
purif
process
analyz
polyacrylamid
gel
use
coomassi
blue
ezblu
gel
stain
reagent
sigma
obtain
protein
desalt
use
desalt
column
ge
healthcar
elut
pb
statist
analysi
twotail
unpair
student
test
use
analyz
differ
mean
valu
group
result
express
mean
standard
deviat
p
valu
consid
signific
supplement
materi
articl
may
found
http
